Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter S Linsley

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Nature Immunology|February 18, 2005
New look at an old costimulatorPeter S Linsley
Discovery Medicine|April 29, 2010
The therapeutic potential of microRNA modulationAimee Jackson, Peter S Linsley
BMC Biology|June 10, 2010
Hidden reach of the micromanagersPeter S Linsley, Aimee L Jackson
Nature Reviews. Drug Discovery|January 1, 2010
Recognizing and avoiding siRNA off-target effects for target identification and therapeutic applicationAimee L Jackson, Peter S Linsley
Nature Biotechnology|September 12, 2007
Mustering the micromanagersLee P Lim, Peter S Linsley
Current Opinion in Endocrinology, Diabetes, and Obesity|June 4, 2019
Enforcing the checkpoints: harnessing T-cell exhaustion for therapy of T1DPeter S Linsley, S Alice Long
Current Opinion in Microbiology|June 12, 2002
Recent developments in DNA microarraysDaniel D Shoemaker, Peter S Linsley
Trends in Genetics : TIG|October 12, 2004
Noise amidst the silence: off-target effects of siRNAs?Aimee L Jackson, Peter S Linsley
Immunological Reviews|May 12, 2009
The clinical utility of inhibiting CD28-mediated costimulationPeter S Linsley, Steven G Nadler
Cold Spring Harbor Perspectives in Medicine|May 21, 2024
Integrating Omics into Functional Biomarkers of Type 1 DiabetesS Alice Long, Peter S Linsley
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Nature Immunology|February 18, 2005
New look at an old costimulatorPeter S Linsley
Discovery Medicine|April 29, 2010
The therapeutic potential of microRNA modulationAimee Jackson, Peter S Linsley
BMC Biology|June 10, 2010
Hidden reach of the micromanagersPeter S Linsley, Aimee L Jackson
Nature Reviews. Drug Discovery|January 1, 2010
Recognizing and avoiding siRNA off-target effects for target identification and therapeutic applicationAimee L Jackson, Peter S Linsley
Nature Biotechnology|September 12, 2007
Mustering the micromanagersLee P Lim, Peter S Linsley
Current Opinion in Endocrinology, Diabetes, and Obesity|June 4, 2019
Enforcing the checkpoints: harnessing T-cell exhaustion for therapy of T1DPeter S Linsley, S Alice Long
Current Opinion in Microbiology|June 12, 2002
Recent developments in DNA microarraysDaniel D Shoemaker, Peter S Linsley
Trends in Genetics : TIG|October 12, 2004
Noise amidst the silence: off-target effects of siRNAs?Aimee L Jackson, Peter S Linsley
Immunological Reviews|May 12, 2009
The clinical utility of inhibiting CD28-mediated costimulationPeter S Linsley, Steven G Nadler
Cold Spring Harbor Perspectives in Medicine|May 21, 2024
Integrating Omics into Functional Biomarkers of Type 1 DiabetesS Alice Long, Peter S Linsley
Pageof 11